tiprankstipranks
Advertisement
Advertisement
Can-Fite Posts Positive Phase 2a Results for Namodenoson in Advanced Pancreatic Cancer
PremiumCompany AnnouncementsCan-Fite Posts Positive Phase 2a Results for Namodenoson in Advanced Pancreatic Cancer
1M ago
Can-Fite BioPharma Sets May 28, 2026 AGM to Vote on Share Capital Increase and Executive Option Grants
Premium
Company Announcements
Can-Fite BioPharma Sets May 28, 2026 AGM to Vote on Share Capital Increase and Executive Option Grants
1M ago
Can-Fite BioPharma files to sell 3.29M ordinary shares for holders
Premium
The Fly
Can-Fite BioPharma files to sell 3.29M ordinary shares for holders
2M ago
Can-Fite Secures Israeli Patent to Bolster Namodenoson Anti-Obesity Franchise
PremiumCompany AnnouncementsCan-Fite Secures Israeli Patent to Bolster Namodenoson Anti-Obesity Franchise
3M ago
Can-Fite BioPharma announces Israeli patent allowance for namodenoson
Premium
The Fly
Can-Fite BioPharma announces Israeli patent allowance for namodenoson
3M ago
Can-Fite BioPharma Shareholders Approve All Proposals at March 10 Special Meeting
Premium
Company Announcements
Can-Fite BioPharma Shareholders Approve All Proposals at March 10 Special Meeting
3M ago
Can-Fite Targets Rare Kidney Disease With New Phase 2 Lowe Syndrome Trial
PremiumCompany AnnouncementsCan-Fite Targets Rare Kidney Disease With New Phase 2 Lowe Syndrome Trial
3M ago
Can-Fite Showcases Namodenoson Anti-Obesity Data in Peer-Reviewed Journal
Premium
Company Announcements
Can-Fite Showcases Namodenoson Anti-Obesity Data in Peer-Reviewed Journal
3M ago
Can-Fite BioPharma announces publication of anti-obesity effect of namodenoson
Premium
The Fly
Can-Fite BioPharma announces publication of anti-obesity effect of namodenoson
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100